Link Between m6A Modification and Cancers

Bansal, 2014, WTAP is a novel oncogenic protein in acute myeloid leukemia, Leukemia, 28, 1171, 10.1038/leu.2014.16

Barbieri, 2017, Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control, Nature, 552, 126, 10.1038/nature24678

Bartosovic, 2017, N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing, Nucleic Acids Res., 45, 11356, 10.1093/nar/gkx778

Batista, 2014, m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells, Cell Stem Cell, 15, 707, 10.1016/j.stem.2014.09.019

Boccaletto, 2018, MODOMICS: a database of RNA modification pathways. 2017 update, Nucleic Acids Res, 46, D303, 10.1093/nar/gkx1030

Bodi, 2015, Yeast m6A Methylated mRNAs are enriched on translating ribosomes during meiosis, and under rapamycin treatment, PLoS ONE, 10, e0132090, 10.1371/journal.pone.0132090

Bokar, 1997, Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase, RNA, 3, 1233

Cai, 2018, HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g, Cancer Lett., 415, 11, 10.1016/j.canlet.2017.11.018

Chen, , YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells, Cell Cycle, 16, 2259, 10.1080/15384101.2017.1380125

Chen, , RNA N6-methyladenosine methyltransferase METTL3 promotes liver cancer progression through YTHDF2 dependent post-transcriptional silencing of SOCS2, Hepatology, 67, 2254, 10.1002/hep.29683

Csepany, 1990, Sequence specificity of mRNA N6-adenosine methyltransferase, J. Biol. Chem., 265, 20117, 10.1016/S0021-9258(17)30477-5

Cui, 2017, m(6)A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells, Cell Rep., 18, 2622, 10.1016/j.celrep.2017.02.059

Dai, 2018, N6-methyladenosine links RNA metabolism to cancer progression, Cell Death Dis, 9, 124, 10.1038/s41419-017-0129-x

Dominissini, 2012, Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq, Nature, 485, 201, 10.1038/nature11112

Du, 2016, YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex, Nat. Commun., 7, 12626, 10.1038/ncomms12626

Du, 2017, MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA, Biochem. Biophys. Res. Commun., 482, 582, 10.1016/j.bbrc.2016.11.077

Esteller, 2017, The epitranscriptome of noncoding RNAs in cancer, Cancer Discov., 7, 359, 10.1158/2159-8290.CD-16-1292

Fröhling, 2005, Genetics of myeloid malignancies: pathogenetic and clinical implications, J. Clin. Oncol., 23, 6285, 10.1200/JCO.2005.05.010

Fu, 2014, Gene expression regulation mediated through reversible m(6)A RNA methylation, Nat. Rev. Genet., 15, 293, 10.1038/nrg3724

Fustin, 2013, RNA-methylation-dependent RNA processing controls the speed of the circadian clock, Cell, 155, 793, 10.1016/j.cell.2013.10.026

Goldaracena, 2017, Current status of liver transplantation for cholangiocarcinoma, Liver Transpl, 24, 294, 10.1002/lt.24955

Hsu, 2017, Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis, Cell Res., 27, 1115, 10.1038/cr.2017.99

Jia, 2013, Reversible RNA adenosine methylation in biological regulation, Trends Genet., 29, 108, 10.1016/j.tig.2012.11.003

Jia, 2011, N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO, Nat. Chem. Biol., 7, 885, 10.1038/nchembio.687

Jin, 2012, Expression and roles of Wilms' tumor 1-associating protein in glioblastoma, Cancer Sci., 103, 2102, 10.1111/cas.12022

Jo, 2013, WTAP regulates migration and invasion of cholangiocarcinoma cells, J. Gastroenterol., 48, 1271, 10.1007/s00535-013-0748-7

Kennedy, 2017, Recent advances in understanding cholangiocarcinoma, F1000Res, 6, 1818, 10.12688/f1000research.12118.1

Kwok, 2017, Genetic alterations of m(6)A regulators predict poorer survival in acute myeloid leukemia, J. Hematol. Oncol., 10, 39, 10.1186/s13045-017-0410-6

Li, , Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation, Cell Res., 27, 444, 10.1038/cr.2017.10

Li, , The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma, Oncotarget, 8, 96103, 10.18632/oncotarget.21726

Li, , FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N(6)-Methyladenosine RNA Demethylase, Cancer Cell, 31, 127, 10.1016/j.ccell.2016.11.017

Lin, 2016, The m(6)A Methyltransferase METTL3 promotes translation in human cancer cells, Mol. Cell, 62, 335, 10.1016/j.molcel.2016.03.021

Liu, 2014, A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation, Nat. Chem. Biol., 10, 93, 10.1038/nchembio.1432

Liu, 2017, N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein, Nucleic Acids Res., 45, 6051, 10.1093/nar/gkx141

Liu, 2018, Human C-to-U coding RNA editing is largely nonadaptive, Mol. Biol. Evol, 35, 963, 10.1093/molbev/msy011

Ma, 2017, METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing, Hepatology, 65, 529, 10.1002/hep.28885

Mauer, 2017, Reversible methylation of m(6)Am in the 5' cap controls mRNA stability, Nature, 541, 371, 10.1038/nature21022

Meyer, 2015, 5' UTR m(6)A promotes cap-independent translation, Cell, 163, 999, 10.1016/j.cell.2015.10.012

Meyer, 2012, Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons, Cell, 149, 1635, 10.1016/j.cell.2012.05.003

Molina, 2008, Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship, Mayo Clin. Proc., 83, 584, 10.4065/83.5.584

Narayan, 1988, An in vitro system for accurate methylation of internal adenosine residues in messenger RNA, Science, 242, 1159, 10.1126/science.3187541

Narayan, 1994, Context effects on N6-adenosine methylation sites in prolactin mRNA, Nucleic Acids Res., 22, 419, 10.1093/nar/22.3.419

Ping, 2014, Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase, Cell Res., 24, 177, 10.1038/cr.2014.3

Rick, 2018, Tumor treating fields: a new approach to glioblastoma therapy, J. Neurooncol, 137, 447, 10.1007/s11060-018-2768-x

Roundtree, 2017, YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs, Elife, 6, e31311, 10.7554/eLife.31311

Shi, 2017, YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA, Cell Res., 27, 315, 10.1038/cr.2017.15

Sledz, 2016, Structural insights into the molecular mechanism of the m(6)A writer complex, Elife, 5, e18434, 10.7554/eLife.18434

Srikantan, 2012, Functional interplay between RNA-binding protein HuR and microRNAs, Curr. Protein Pept. Sci., 13, 372, 10.2174/138920312801619394

Su, 2018, R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m(6)A/MYC/CEBPA Signaling, Cell, 172, 90, 10.1016/j.cell.2017.11.031

Tanabe, 2016, RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1alpha mRNA is translated, Cancer Lett., 376, 34, 10.1016/j.canlet.2016.02.022

Visvanathan, 2018, Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance, Oncogene, 37, 522, 10.1038/onc.2017.351

Vu, 2017, The N(6)-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells, Nat. Med., 23, 1369, 10.1038/nm.4416

Wang, , Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases, Mol. Cell, 63, 306, 10.1016/j.molcel.2016.05.041

Wang, , Roles of RNA methylation by means of N(6)-methyladenosine (m(6)A) in human cancers, Cancer Lett., 408, 112, 10.1016/j.canlet.2017.08.030

Wang, , Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex, Nature, 534, 575, 10.1038/nature18298

Wang, , Reduced m(6)A mRNA methylation is correlated with the progression of human cervical cancer, Oncotarget, 8, 98918, 10.18632/oncotarget.22041

Wang, , N6-methyladenosine-dependent regulation of messenger RNA stability, Nature, 505, 117, 10.1038/nature12730

Wang, 2015, N(6)-methyladenosine modulates messenger RNA translation efficiency, Cell, 161, 1388, 10.1016/j.cell.2015.05.014

Wang, , N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells, Nat. Cell Biol., 16, 191, 10.1038/ncb2902

Weng, 2017, METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification, Cell Stem Cell, 22, 191, 10.1016/j.stem.2017.11.016

Whitesell, 2005, HSP90 and the chaperoning of cancer, Nat. Rev. Cancer, 5, 761, 10.1038/nrc1716

Wickramasinghe, 2015, Control of mammalian gene expression by selective mRNA export, Nat. Rev. Mol. Cell Biol., 16, 431, 10.1038/nrm4010

Wu, 2018, Role of DNA and RNA N6-Adenine methylation in regulating stem cell fate, Curr. Stem Cell Res. Ther., 13, 31, 10.2174/1574888X12666170621125457

Xi, 2016, WTAP expression predicts poor prognosis in malignant glioma patients, J. Mol. Neurosci., 60, 131, 10.1007/s12031-016-0788-6

Xiao, 2016, Nuclear m(6)A reader YTHDC1 regulates mRNA splicing, Mol. Cell, 61, 507, 10.1016/j.molcel.2016.01.012

Xu, 2014, Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain, Nat. Chem. Biol., 10, 927, 10.1038/nchembio.1654

Yang, 2018, Precision therapy for acute myeloid leukemia, J. Hematol. Oncol., 11, 3, 10.1186/s13045-017-0543-7

Yang, 2017, MicroRNA-145 modulates N(6)-methyladenosine levels by targeting the 3'-Untranslated mRNA Region of the N(6)-Methyladenosine binding YTH Domain family 2 Protein, J. Biol. Chem., 292, 3614, 10.1074/jbc.M116.749689

Zhang, , Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m(6)A-demethylation of NANOG mRNA, Proc. Natl. Acad. Sci. U.S.A., 113, E2047, 10.1073/pnas.1602883113

Zhang, , Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells, Oncotarget, 7, 64527, 10.18632/oncotarget.11743

Zhang, 2017, m(6)A Demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program, Cancer Cell, 31, 591, 10.1016/j.ccell.2017.02.013

Zhao, 2017, Post-transcriptional gene regulation by mRNA modifications, Nat. Rev. Mol. Cell Biol., 18, 31, 10.1038/nrm.2016.132

Zhao, 2014, FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis, Cell Res., 24, 1403, 10.1038/cr.2014.151

Zheng, 2013, ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility, Mol. Cell, 49, 18, 10.1016/j.molcel.2012.10.015

Zhou, 2015, Dynamic m(6)A mRNA methylation directs translational control of heat shock response, Nature, 526, 591, 10.1038/nature15377

Zhou, 2018, FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation, Mol. Carcinog, 57, 590, 10.1002/mc.22782